Results 91 to 100 of about 4,524 (132)

Sequential Analysis of Murine Myelofibrosis Models Using a Novel Deep Learning-Based Fibrosis Quantitative Method. [PDF]

EJHaem
Kawamura T, Maekawa T, Kouzu K, Ogata H, Tachi N, Kato S, Osawa Y, Einama T, Sato K, Kobayashi S.   +9 more
europepmc   +1 more source

Rovadicitinib, a first-in-class JAK/ROCK inhibitor, in patients with myelofibrosis: a preclinical and phase I study. [PDF]

Blood Cancer J
Xu Z, Liu J, Hong Z, Yin Q, Zuo X, Wen Q, Li L, Chang C, Du X, Wang Y, Yang X, Yang C, Jia H, Pan L, Xiao Z.   +14 more
europepmc   +1 more source

Megakaryocytes in myelofibrosis: mechanisms of fibrotic niche remodeling and therapeutic implications. [PDF]

Biomark Res
Huang J, Yin X, Shi X, Yang X, Li R, Zhang X, Zhang Y, Tong H, Jin J, Huang J.   +9 more
europepmc   +1 more source

Prime time for the use of statins in MPNs: from comorbidity drugs to disease-modifying partners. [PDF]

Blood Adv
Hasselbalch HC.
europepmc   +1 more source

Ruxolitinib treatment in patients with polycythemia vera reduces <i>JAK2</i> variant allele frequency and improves symptom burden and hematocrit control. [PDF]

Ther Adv Hematol
Harrison CN, Kiladjian JJ, Hamer-Maansson JE, Naim A, Palandri F, Passamonti F.   +5 more
europepmc   +1 more source

Hematologic and molecular response to ropeginterferon alfa-2b in patients with polycythemia vera: a systematic review and meta-analysis. [PDF]

Ann Hematol
Elgadi A, Wagealla M, Noorallah T, Esmail R, Almahi SS.   +4 more
europepmc   +1 more source

JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms. [PDF]

Leukemia
Kealy D, Ellerington R, Bansal S, Medeiros JJF, Hawley CA, Zeng AGX, Lukaszonek J, West KA, Sinha AD, Caalim G, Gawne RT, Pope J, Ferreira BL, Blacknell NM, Drylie B, Chatzigerou J, Khoo HM, Wilkinson AC, Fielding AK, Wang G, Psaila B, Kent DG, Hitchcock IS, Holding AN, Mason AS, Gupta V, Dick JE, Bridge KS.   +27 more
europepmc   +1 more source

Mutant calreticulin-Cancer driver and Achilles' heel for ET? [PDF]

Hemasphere
Reichert M, Psaila B.
europepmc   +1 more source

Ropeginterferon alfa-2b for prefibrotic myelofibrosis and lower-risk myelofibrosis requiring cytoreduction. [PDF]

Blood Adv
Gill H, Au L, Yim R, Lee P, Li V, Chin L, Zhang Q, Chan PY, Lee CYY, Wu TKY, Leung GMK, Kwong YL.   +11 more
europepmc   +1 more source